Trevena
1 known investors
Find your way into Trevena
Trevena develops and commercializes innovative pharmaceutical therapies for central nervous system disorders. The company has an FDA-approved drug (OLINVYK) and multiple investigational candidates targeting migraine, opioid use disorder, and neuropathic pain.
Investors · 1
Frequently asked questions
- What does Trevena do?
- Trevena develops and commercializes innovative pharmaceutical therapies for central nervous system disorders. The company has an FDA-approved drug (OLINVYK) and multiple investigational candidates targeting migraine, opioid use disorder, and neuropathic pain.
- Who are Trevena's investors?
- Trevena's investors include New Enterprise Associates (NEA).